{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:02:59Z","timestamp":1789725779254,"version":"4.0.1"},"reference-count":33,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018270","name":"Health Service Executive","doi-asserted-by":"publisher","award":["Spark Innovation Fund"],"award-info":[{"award-number":["Spark Innovation Fund"]}],"id":[{"id":"10.13039\/100018270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2026,7,26]]},"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Specific to normal gastric epithelium, Claudin 18.2 (CLDN18.2) is a tight junction protein. CLDN18.2 immunohistochemistry is a companion diagnostic used to identify oesophageal and gastric adenocarcinoma patients eligible for targeted therapy with zolbetuximab. It has demonstrated survival benefits in advanced upper gastrointestinal (UGI) cancers, with many studies now exploring its potential use beyond the UGI tract. This study aimed to examine CLDN18.2 expression in a peritoneal malignancy patient cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      CLDN18.2 immunohistochemistry was performed on archived tissue from patients who underwent cytoreductive surgery at a national centre for peritoneal malignancy. CLDN18.2 immunoprofiles were compared in two key tumour cohorts: peritoneal metastases from colorectal adenocarcinoma and appendiceal mucinous neoplasms. Positivity was defined as moderate-to-strong membranous staining in\n                      <jats:underline>&gt;<\/jats:underline>\n                      75% of tumour cells. In addition, any CLDN18.2 positivity in tumour cells (&gt;0% of cells showing moderate-to-strong membranous staining) was recorded in all cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>64 cases were examined; primary tumour sites of origin were colorectal (n=34, 53%) and appendiceal (n=30, 47%). CLDN18.2 positivity in the overall appendiceal group was 17% compared with 3% in colorectal adenocarcinomas (p=0.090). In the appendiceal group, CLDN18.2 positivity was only demonstrated in high-grade appendiceal mucinous carcinomas (22%, 5 of 23). CLDN18.2 positive staining (&gt;0% of tumour cells) was significantly increased in the appendiceal group compared with colorectal adenocarcinoma (53% vs 3%, respectively) (p&lt;0.0001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results demonstrate CLDN18.2 expression in a subset of appendiceal peritoneal metastases. This is one of the first focused studies showing CLDN18.2 expression in this tumour group, perhaps highlighting a future role for targeted therapies in those with limited curative oncological options.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jcp-2026-210851","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:20:29Z","timestamp":1786036829000},"page":"696-701","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective analysis of Claudin 18.2 expression in 64 patients with advanced gastrointestinal peritoneal disease: a potential therapeutic target for high-grade appendiceal mucinous carcinoma"],"prefix":"10.1136","volume":"79","clinical-trial-number":[{"clinical-trial-number":"nct03816163","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Colman T","family":"Clarke","sequence":"first","affiliation":[{"name":"Department of Cellular Pathology, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailin C","family":"Rogers","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mater Misericordiae University Hospital, Dublin, Ireland"},{"name":"School of Medicine, University College Dublin - National University of Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Cowzer","sequence":"additional","affiliation":[{"name":"School of Medicine, University College Dublin - National University of Ireland, Dublin, Ireland"},{"name":"Department of Oncology, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Treacy","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Mater Misericordiae University Hospital, Dublin, Ireland"},{"name":"School of Medicine, University College Dublin - National University of Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Aird","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Mater Misericordiae University Hospital, Dublin, Ireland"},{"name":"School of Medicine, University College Dublin - National University of Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mater Misericordiae University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Mulsow","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mater Misericordiae University Hospital, Dublin, Ireland"},{"name":"School of Medicine, University College Dublin - National University of Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0247-6953","authenticated-orcid":false,"given":"Naoimh J","family":"O\u2019Farrell","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Mater Misericordiae University Hospital, Dublin, Ireland"},{"name":"School of Medicine, University College Dublin - National University of Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"2026091802100896000_79.10.696.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.02.005"},{"key":"2026091802100896000_79.10.696.2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)00620-7"},{"key":"2026091802100896000_79.10.696.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02465-7"},{"key":"2026091802100896000_79.10.696.4","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1547"},{"key":"2026091802100896000_79.10.696.5","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.21.21.7380-7390.2001"},{"key":"2026091802100896000_79.10.696.6","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyz068"},{"key":"2026091802100896000_79.10.696.7","doi-asserted-by":"crossref","DOI":"10.1200\/PO.23.00543","article-title":"Retrospective Study of Claudin 18 Isoform 2 Prevalence and Prognostic Association in Gastric and Gastroesophageal Junction Adenocarcinoma","volume":"8","author":"Waters","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"2026091802100896000_79.10.696.8","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.21037\/jgo-20-344","article-title":"Highly expressed Claudin18.2 as a potential therapeutic target in advanced gastric signet-ring cell carcinoma (SRCC)","volume":"11","author":"Xu","year":"2020","journal-title":"J Gastrointest Oncol"},{"key":"2026091802100896000_79.10.696.9","doi-asserted-by":"crossref","DOI":"10.1200\/PO-24-00925","article-title":"Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological Factors","volume":"9","author":"Jubashi","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"2026091802100896000_79.10.696.10","doi-asserted-by":"crossref","first-page":"100712","DOI":"10.1016\/j.modpat.2025.100712","article-title":"Claudin 18.2 Expression in 1404 Digestive Tract Adenocarcinomas Including 1175 Colorectal Carcinomas: Distinct Colorectal Carcinoma Subtypes Are Claudin 18.2 Positive","volume":"38","author":"McHugh","year":"2025","journal-title":"Mod Pathol"},{"key":"2026091802100896000_79.10.696.11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17233764","article-title":"CLDN18.2-Targeted Therapy in Gastrointestinal Cancers","volume":"17","author":"Dominguez Wiscovitch","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026091802100896000_79.10.696.12","doi-asserted-by":"crossref","unstructured":"Ang CS-P , Shen JP , Hardy-Abeloos CJ , et al . Genomic Landscape of Appendiceal Neoplasms. JCO Precis Oncol 2018;2. doi:10.1200\/PO.17.00302","DOI":"10.1200\/PO.17.00302"},{"key":"2026091802100896000_79.10.696.13","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21679"},{"key":"2026091802100896000_79.10.696.14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604522"},{"key":"2026091802100896000_79.10.696.15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24715"},{"key":"2026091802100896000_79.10.696.16","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1023\/A:1021065407822","article-title":"Adenocarcinoid of the appendix vermiformis: complete and persistent remission after chemotherapy (folfox) of a metastatic case","volume":"47","author":"Garin","year":"2002","journal-title":"Dig Dis Sci"},{"key":"2026091802100896000_79.10.696.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-02037-5"},{"key":"2026091802100896000_79.10.696.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2021.04.004"},{"key":"2026091802100896000_79.10.696.19","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s11845-021-02506-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: outcomes from a national centre in the current era","volume":"190","author":"Kelly","year":"2021","journal-title":"Ir J Med Sci"},{"key":"2026091802100896000_79.10.696.20","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2023-0001"},{"key":"2026091802100896000_79.10.696.21","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000535"},{"key":"2026091802100896000_79.10.696.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-023-10533-x","article-title":"Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"key":"2026091802100896000_79.10.696.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2014.04.018"},{"key":"2026091802100896000_79.10.696.24","doi-asserted-by":"crossref","DOI":"10.1002\/gcc.23270","article-title":"Molecular Profiling of Low-Grade Appendiceal Mucinous Neoplasms (LAMN)","volume":"63","author":"Doll","year":"2024","journal-title":"Genes Chromosomes Cancer"},{"key":"2026091802100896000_79.10.696.25","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.47"},{"key":"2026091802100896000_79.10.696.26","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03321-8"},{"key":"2026091802100896000_79.10.696.27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/his.14358","article-title":"Colitis-associated colorectal adenocarcinomas frequently express claudin 18 isoform 2: implications for claudin 18.2 monoclonal antibody therapy","volume":"79","author":"Iwaya","year":"2021","journal-title":"Histopathology"},{"key":"2026091802100896000_79.10.696.28","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v14.i7.1252"},{"key":"2026091802100896000_79.10.696.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2014.11.029"},{"key":"2026091802100896000_79.10.696.30","doi-asserted-by":"crossref","DOI":"10.1186\/gm559","article-title":"Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin","volume":"6","author":"Alakus","year":"2014","journal-title":"Genome Med"},{"key":"2026091802100896000_79.10.696.31","doi-asserted-by":"crossref","unstructured":"Trinh VQ-H , Ankenbauer KE , Torbit SM , et al . Mutant gnas drives a pyloric metaplasia with tumor suppressive glycans in intraductal papillary mucinous neoplasia. Cancer Biology [Preprint]. doi:10.1101\/2024.02.25.581948","DOI":"10.1101\/2024.02.25.581948"},{"key":"2026091802100896000_79.10.696.32","doi-asserted-by":"publisher","DOI":"10.1136\/jcp-2025-210328"},{"key":"2026091802100896000_79.10.696.33","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.104000","article-title":"Clinicopathological analysis of claudin 18.2 focusing on intratumoral heterogeneity and survival in patients with metastatic or unresectable gastric cancer","volume":"9","author":"Kim","year":"2024","journal-title":"ESMO Open"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp-2026-210851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:10:46Z","timestamp":1789722646000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp-2026-210851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":33,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,18]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/jcp-2026-210851"],"URL":"https:\/\/doi.org\/10.1136\/jcp-2026-210851","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}